Neurosyphilis - Part 2
In part 2 of a 3 part series, Felicia Chow, MD, MAS, discusses her article, “Neurosyphilis" from the August Neuroinfectious Disease Continuum issue. T...
Neurology Minute
Share:
Listens: 2481
About
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, PhD, FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Neurosyphilis - Part 1
In part 1 of a 3 part series, Felicia Chow, MD, MAS, discusses her article, “Neurosyphilis" from the August Neuroinfectious Disease Continuum issue. T...
Neurologic Safety Monitoring of COVID-19 Vaccines
Dr. Jason Crowell talks with Dr. Kiran Thakur about the importance of monitoring COVID-19 vaccines for neurologic adverse events and learning from pas...
Movement Disorders in Anti-IgLON5 Disease
Dr. Jeff Ratliff interviews Dr. Carles Gaig about the frequency and types of movement disorders in patients with anti-IgLON5 disease.
Careers in Neurology: Neuro-oncology
Dr. Katrina Ignacio discusses the emerging subspecialty of Neuro-oncology.
Seizures, Status Epilepticus, and Continuous EEG in the Intensive Care Unit - Part 2
In part 2 of a 2 part series, Eric S. Rosenthal, MD, discusses the article, “Seizures, Status Epilepticus, and Continuous EEG in the Intensive Care Un...
Seizures, Status Epilepticus, and Continuous EEG in the Intensive Care Unit - Part 1
In part 1 of a 2 part series, Eric S. Rosenthal, MD, discusses the article, “Seizures, Status Epilepticus, and Continuous EEG in the Intensive Care Un...
The Changing Face of Osmotic Demyelination Syndrome
Dr. Pearce Korb discusses the long-term outcomes of osmotic demyelination syndrome in an updated cohort with Dr. Whitney Fitts.
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. Show references: https://www....